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Abstract: In the last 10 years, value has played a key role in the health care system. In this 
concept, innovations in medical practice and the increasing importance of patient centeredness 
have contributed to draw the attention of the medical community. Nonetheless, a large consensus 
on the meaning of “value” is still lacking: patients, physicians, policy makers, and other health 
care professionals have different ideas on which component of value may play a prominent 
role. Yet, shared clinical decision-making and patient empowerment have been recognized as 
fundamental features of the concept of value. Different paradigms of health care system embrace 
different meanings of value, and the absence of common and widely accepted definition does not 
help to identify a unique model of care in health care system. Our aim is to provide an overview 
of those paradigms that have considered value as a key theoretical concept and to investigate 
how the presence of value can influence the medical practice. This article may contribute to 
draw attention toward patients and propose a possible link between health care system based 
on “value” and new paradigms such as patient-centered system (PCS), patient empowerment, 
and P5 medicine, in order to create a predictive, personalized, preventive, participatory, and 
psycho-cognitive model to treat patients. Indeed, patient empowerment, value-based system, 
and P5 medicine seem to shed light on different aspects of a PCS, and this allows a better 
understanding of people under care.
Keywords: health care system, value, value-based medicine, patient empowerment, clinical 
decision-making, patient centeredness
Introduction
Nowadays, the concept of value is a prominent topical issue in health care. Individual 
needs, wishes, preferences, and ethics influence the meaning of value which, in turn, 
is influenced by different cultures or historical periods.1 The necessity of finding better 
ways of redirecting the incentives away from volume and toward value pushes patients, 
physicians, policy makers, and other stakeholders to turn their attention toward what 
value means and what are the main features of this concept.2 Even if there is still no 
unanimous agreement on value’s definition, it is commonly accepted that values in 
health care may be defined as normative guidelines helping us to evaluate actions or 
situations and influencing the decision-making process.3–5
Different studies point out how the definition of value changes according to the 
reference sample: doctors’ values, most of the time, do not match the values of the 
patients, and vice versa.3,6,7
The presence of different opinions encourages some reputable organizations and 
associations to base their definitions of value on expert judgment or on empirical studies 
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that correlate attributes of value with a measurable outcome. 
According to this, the American Heart Association (AHA) 
underlines that, even though clinical efficacy and outcomes 
constitute the primary basis of good medical practice, value 
plays – together with costs – an important role, and it includes 
positive results in patient’s outcome, safety, and satisfaction 
at a total cost that is reasonable and affordable.6 However, in 
2008, the Institute of Medicine7 (IOM) held a 2-day workshop 
to explore key stakeholders’ perspectives on value in health 
care, seeking to understand the meaning of value. Finding a 
mutually acceptable agreement among the different points 
of view, as expressed by patients, providers, economists, 
payers, and employers, is understandably complex. In fact, 
providers considered value on the basis of appropriateness of 
care and effective, evidence-based interventions; economic 
representatives defined value as the clinical benefit achieved 
for the money spent. Patients, however, place their attention 
on the ability of health care to satisfy their goals: a valuable 
intervention is a way of treating that also fulfills their needs.8 
Indeed, from a patient’s perspective, the burden of illness 
is not limited to disease status, but it is also important to 
consider quality of life (QoL) factors and, more precisely, 
health-related QoL, referring to its clinical dimension. 
Patient’s needs are frequently measured taking into account 
different aspects of QoL, such as pain, emotional and cog-
nitive functioning, or functional impairment.9,10 Moreover, 
a recent review11 on patient’s perceptions of quality of care 
emphasizes how communication, health care access, and 
shared decision-making (SDM) are the key elements in a 
valuable health care environment.
Nowadays, even if we narrow our attention to the medi-
cal context, we are not able to identify the core features of a 
health care system based on value because every paradigm 
adopts different definitions of value. The absence of common 
and widely accepted meaning allows each movement in health 
care practice to take into account different components of 
value identifying different model, of care. The aim of this 
article is to provide an overview of the main approaches of the 
last 10 years that have considered value as the key theoretical 
concept. As we shall see, each movement adopts a particular 
definition of value leading to a different application of these 
paradigms in the health care system.
From evidence-based medicine (EBM) 
toward value-based medicine (VBM)
Two decades ago, the EBM was the first movement in 
health care that disregarded the paternalistic approach and 
 revolutionized the idea of doing science. The EBM intro-
duced a new way to make good clinical decisions: health care 
 decisions should be based on the best available evidence mixed 
with the clinical expertise.12 External evidence and clinical 
expertise must be integrated with patients’ preferences in 
making medical decisions about their care; only in this way, 
doctors will be able to identify the best interventions to maxi-
mize QoL of patients and minimize the cost of their care.13
Despite its success throughout the scientific world, some 
researchers have started asking whether this paradigm has 
been facing a crisis. Among different reasons, Greenhalgh 
et al14 suggested that, during the course of the years, EBM has 
forgotten the importance of individualism. Evidence should 
be understandable by all patients, practitioners, and other 
stakeholders, and they should share discoveries and fears to 
take reasonable decisions.14 At the same time, preferences, 
wishes, thoughts, and all individual aspects of patients were 
included in the conceptual label of value, becoming like a 
constellation of principles with an important role in life. Fol-
lowing the definition of Sackett et al15 with “patient values 
we mean the unique preferences, concerns and expectations 
each patient brings to a clinical encounter and which must 
be integrated into clinical decisions if they are to serve the 
patient.”
In the last 10 years, to re-emphasize the importance of 
patients’ preferences and QoL, new paradigms were born, 
turning their attention toward individual aspects and focus-
ing on patient’s value. Consequently, health care paradigms 
faced a shift from EBM to VBM. The term “value-based” 
was first introduced by Brown et al who defines this new 
paradigm as “the practice of medicine incorporating the 
highest level of evidence-based data with the patient per-
ceived value conferred by health care interventions for the 
resources expended.”16
EBM focuses its attention on clinical trial results and uses 
these data to provide the best care and, in the meanwhile, it 
usually ignores the importance of QoL improvement. Instead, 
the VBM leads to a higher level the discoveries of EBM cal-
culating the value of operations in medical practice, based 
on pharmacoeconomic principles.1 The value is measured 
objectively by calculating the improvement in QoL and life 
expectancy after surgery: the result is the benefit derived from 
an intervention for the costs expended.17,18 In other words, 
VBM takes EBM to a higher level, including the QoL in the 
data analysis and interpreted the data in relation to the value 
and costs of an intervention. In so doing, VBM utilizes a 
health care economic cost–utility analysis where results could 
be interpreted in terms of $/QALY (quality-adjusted life 
year), considering the dollars spent for the improvement in 
length of life and/or QoL on a continuum from 0.0 (death) to 
1.0 (perfect health).19 QALY is the arithmetic product of life 
Journal of Multidisciplinary Healthcare 2017:10 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
103
Value as the key concept in the health care system
expectancy combined with the measurement of the quality 
of remaining life years.20 The choice of the “right methodol-
ogy” had been controversial, and they finally opted for a time 
trade-off cost–utility analysis since it would be applicable in 
any specialty of medicine, allowing a comparison across dif-
ferent interventions.18,21 Time trade-off methodology consists 
in “asking a person how many additional years he or she 
expects to live and, at the same time, how much time he or 
she would be willing to trade in return for a treatment that 
would guarantee their conversion in a normal health state.”21,22
In summary, VBM underlies the value aspect missing in 
EBM. In particular, EBM provides data that are converted to 
a measure of value through a cost–utility analysis and later 
combined with costs.1
Both VBM and EBM are paradigms involved in the 
growing complexity of decision-making process in health 
care because values and evidences affect all medical deci-
sions.23,24 In fact, the increasing complication of evidences 
(from which clinical decision-making depends) and values 
(on which clinical decision-making is based) add up to a 
general growth of complexity in medicine, inspiring the 
necessity for an evidence and value-based practice (VBP).
Today, a variety of disciplines play a significant role in 
clinical decision-making in day-to-day practice: medical 
humanities, social sciences, decision analysis, and health 
economics are only some of those that influence patient’s 
choices.25–28 Consequently, the aim of VBP is to integrate 
complex and conflicting values in the process of medical 
decision-making through a skill-based approach where clini-
cians could make medical decisions on the basis of scientific 
evidence and social, ethical, and political values.2,29
A health care system based on value
Another way to facilitate clinical decision-making and 
patient centeredness in health care is to organize the process 
of care around the concept of value: a health care system 
based on value has as a key component, the enhancement 
of patient–doctor communication, and the use of SDM. In 
accordance with this, a study showed that 69% of patients 
with lung cancer and 81% of patients with colorectal cancer 
experienced some difficulties in understanding the goals 
of their treatments and, consequently, they were not able to 
make aware decisions.30
Between 2006 and 2013 at the Institute for Strategy and 
Competitiveness, based at the Harvard Business School, 
Porter and Teisberg developed and proposed a new health 
care  system based on value, “a breakthrough framework for 
redefining health care competition based on patient value.”31
According to value-based principles, a health care system 
should co-create and measure outcomes that are meaning-
ful for patients with similar needs along the whole care 
pathway.32
A value-based health system should refer to three impor-
tant principles.33 First, its proper goal should be the value it 
provides to the patient. In health care, the meaning of value 
varies along a continuum where psychological and physical 
outcomes meet costs. In fact, we can refer to value either from 
a psychological or from an economic perspective. Following 
Porter’s idea, value is expressed as the best “health outcomes 
achieved per dollar spent.”34 By “health outcomes”, it is meant 
the health results that matter for the patient’s condition over 
the care cycle, and by “costs”, they refer to the total costs of 
care for patient’s condition over the care cycle.
Second, treatment delivery should be based on medical 
conditions, and on the course of treatment, a patient has to 
undergo treatment and, finally, outcomes should be measur-
able and recorded.35 Data must be collected along the entire 
patient cycle of care because the outcomes achieved are more 
effective measures than the number of services delivered – 
that we could not previously know if they are properly and 
successfully used. Moreover, outcomes should be interpreted 
on the basis of the true costs effectively delivered across 
the full care cycle because cost reduction without consider-
ing outcomes is dangerous and self-defeating. Value-based 
approaches consider cost measurement in a similar way to 
outcomes measurement, that is, around individual patients 
for all their care, rather than the cost of each organization 
delivering care.33,36
A particular example where cost measurement is always 
integrated with other patient’s outcomes measurement is 
represented by the area of rare diseases. In such context, 
treatment options are not so widely available, and they are 
very expensive; the treatment care plan is usually highly 
personalized and centered on patient’s health status and 
well-being taking into account the budget and patients’ rated 
outcomes.37,38 The right strategy for a high-value health care 
delivery system also includes the organization of care around 
customer’s preferences, implementing an integrated practice 
unit where multidisciplinary personnel works together to 
serve groups of patients with similar primary and preventive 
care needs.32,35
The attention toward the health care system shifts from a 
volume of activity approach to a value-based system, focused 
on results concretely obtained:34 as Porter and Lee affirm, 
this proposal is an “inevitable change”: increasing value in 
health is the only one real solution.39
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Discussion
A value-based system goes hand in hand with patient centered-
ness: today’s fragmented health care system should move toward 
what patients want, considering and respecting their feelings in 
clinical procedures. Health care management is clearly mov-
ing toward a patient-centered system (PCS), where outcomes 
achieved and units organized around the patient’s needs are the 
main guidelines for the delivery of high-value care.32,40 In fact, 
the IOM defines patient-centered care as “care that is respect-
ful of and respective to individual patient preference, needs 
and values, and ensure that patient values guide all clinical 
decisions.”41,42 Biological information must be integrated with 
beliefs and cognitive dispositions to empower patients and make 
them active participant in the treatment process.43
These features are also stressed by the P5 medicine 
approach to build a medicine that involves both medical and 
psycho-cognitive aspects. The health care system is moving 
toward a P5 medicine, which is a predictive, personalized, 
preventive, participatory, and psycho-cognitive medicine. The 
fifth P refers to an integration among needs, values, cognitive 
dispositions, and medical information, between psychologi-
cal and biological aspects.41 The necessity of a psychological 
and cognitive profile, instead of a mere diagnostic patient’s 
classification, leads to an assessment with psychometric tools 
that include cognitive, decision-making, and mental aspects, 
as well as clinical ones.
The consideration of all these aspects is important to 
empower the patient, improve his/her QoL, and move toward 
their becoming an active decision-maker.43 To obtain a com-
plete evaluation of medical treatment and to determine its 
value, it is necessary both balancing the costs with the ben-
efits and considering the range of patient preferences or costs 
offsets: only with a careful assessment of all these aspects, 
high-value care will be provided. If we do not keep in mind 
outcomes, safety, and patient satisfaction, we could run into 
unexpected costs and lower level of care. Nowadays, differ-
ent studies and updated clinical practice guidelines underline 
the importance of heeding both costs and values if we want a 
health care system effectively patient centered. New norma-
tive guidelines should include value and cost to achieve best 
performance measures and improve all health care system, as 
we can read on the report of American College of Cardiology/
AHA statement on cost/value methodology.6 These guidelines 
should give some important recommendations for appropri-
ate exercise testing in patients with cardiovascular disease.44
On the basis of these recommendations, a recent ran-
domized trial45 regarding diagnostic testing in women with 
suspected coronary artery disease demonstrated how the only 
difference between two groups (treadmill exercise electrocar-
diographic testing vs exercise myocardial perfusion imaging) 
was costs and not outcomes: the first intervention was more 
cost-effective and less invasive than the second one. This 
example shows how cost considerations can be informed by 
patient’s values.
A good physician should be able to communicate in the 
right way with patients and to assess their health literacy and 
comprehension regarding different treatment options, pos-
sible benefits, and harm.46 These features are fundamental in 
the clinical decision-making process and are a cornerstone 
in a value-based health system. Indeed, one of the main rec-
ommendations to implement a value-based health system is 
to actively involve the patient in his or her process of care.33
At the same time, medicine and the whole health care 
system are facing a shift toward the patient empowerment 
paradigm that is linked with different aspects of patient 
participation. Although there is no unanimous agreement, 
current studies define this paradigm as a multidimensional 
concept where communication, decision, and health care 
system combined together and converge in the enhancement 
of the patient.47,48 Every definition emphasizes a specific 
aspect of the empowerment process: awareness, responsibility, 
participation in the care process, SDM, and patient–doctor 
communication. An empowered patient has developed specific 
abilities to interact with the health care system and to make 
better choices that include value for him or her. An empower-
ment process allows the patient to be an active and effective 
participant in their process of care and to look for valuable 
and useful information for their health. This is why empow-
erment should be considered in each step of the value chain 
and should influence the decision-making process in a PCS.
These features are also prominent in the value health 
care model and attach importance to psychological aspects 
influencing the process of care because empowered patients 
become effective people, able to choose valuable paths of 
care and of life.
Conclusion
The value-based system refers to a personalized care, where 
patient’ expectations and needs are included in a holistic 
approach of medicine that considers physical, mental, and 
spiritual well-being. Physicians and patients should change 
their points of view, implementing a new process of care 
where they are actively and equally involved, each of them 
with their expertise: one with clinical knowledge and the 
other with his/her life. They are experts of different but 
equally important subjects.
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Patient empowerment, value-based system, and P5 medi-
cine seem to shed light on different aspects of a PCS, and this 
allows a better understanding of patients and their families 
in managing health and health care.
Therefore, the value-based health system and patient 
empowerment should be considered together, two sides of 
the same coin. Patient’s value may be fully expressed only 
when patients are the main actors of their care, and this means 
when they are fully empowered.
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